11/18
10:31 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Morgan Stanley from $26.00 to $28.00. They now have an "underweight" rating on the stock.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Morgan Stanley from $26.00 to $28.00. They now have an "underweight" rating on the stock.
11/15
08:28 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $50.00 price target on the stock.
Medium
Report
Veracyte, Inc. (NASDAQ: VCYT) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $50.00 price target on the stock.
11/9
08:53 am
vcyt
Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
Medium
Report
Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
11/8
10:34 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Scotiabank from $40.00 to $44.00. They now have a "sector outperform" rating on the stock.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Scotiabank from $40.00 to $44.00. They now have a "sector outperform" rating on the stock.
11/8
06:36 am
vcyt
Veracyte Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Veracyte Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/7
12:35 pm
vcyt
Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised [Yahoo! Finance]
Medium
Report
Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised [Yahoo! Finance]
11/7
12:32 pm
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $34.00 to $38.00. They now have a "buy" rating on the stock.
Medium
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $34.00 to $38.00. They now have a "buy" rating on the stock.
11/7
11:20 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at UBS Group AG from $43.00 to $46.00. They now have a "buy" rating on the stock.
Medium
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at UBS Group AG from $43.00 to $46.00. They now have a "buy" rating on the stock.
11/7
10:28 am
vcyt
Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook [Yahoo! Finance]
Medium
Report
Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook [Yahoo! Finance]
11/7
08:36 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Needham & Company LLC from $37.00 to $44.00. They now have a "buy" rating on the stock.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Needham & Company LLC from $37.00 to $44.00. They now have a "buy" rating on the stock.
11/6
07:28 pm
vcyt
Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates [Yahoo! Finance]
Medium
Report
Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates [Yahoo! Finance]
11/6
04:54 pm
vcyt
Veracyte Announces Third Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
Veracyte Announces Third Quarter 2024 Financial Results [Yahoo! Finance]
11/6
04:05 pm
vcyt
Veracyte Announces Third Quarter 2024 Financial Results
Low
Report
Veracyte Announces Third Quarter 2024 Financial Results
11/5
07:56 am
vcyt
What To Expect From Veracyte Inc (VCYT) Q3 2024 Earnings [Yahoo! Finance]
Low
Report
What To Expect From Veracyte Inc (VCYT) Q3 2024 Earnings [Yahoo! Finance]
10/30
05:00 pm
vcyt
Veracyte to Participate in Upcoming Investor Conferences
Medium
Report
Veracyte to Participate in Upcoming Investor Conferences
10/17
03:15 pm
vcyt
Ark Invest's flagship fund realized $3.5 billion in losses in a year. Here were its 10 biggest losers. [Yahoo! Finance]
Low
Report
Ark Invest's flagship fund realized $3.5 billion in losses in a year. Here were its 10 biggest losers. [Yahoo! Finance]
10/17
11:36 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Leerink Partners from $35.00 to $40.00. They now have an "outperform" rating on the stock.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) had its price target raised by analysts at Leerink Partners from $35.00 to $40.00. They now have an "outperform" rating on the stock.
10/16
06:50 pm
vcyt
Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024 [Yahoo! Finance]
Medium
Report
Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024 [Yahoo! Finance]
10/16
06:43 pm
vcyt
Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024
Medium
Report
Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024
10/16
08:24 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $43.00 price target on the stock.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $43.00 price target on the stock.
10/10
08:34 am
vcyt
Veracyte, Inc. (NASDAQ: VCYT) is now covered by analysts at Guggenheim. They set a "buy" rating and a $40.00 price target on the stock.
Low
Report
Veracyte, Inc. (NASDAQ: VCYT) is now covered by analysts at Guggenheim. They set a "buy" rating and a $40.00 price target on the stock.
10/2
08:25 am
vcyt
New Data Presented at ASTRO 2024 Show that Veracyte's Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men [Yahoo! Finance]
Medium
Report
New Data Presented at ASTRO 2024 Show that Veracyte's Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men [Yahoo! Finance]
10/2
08:20 am
vcyt
New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men
Medium
Report
New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men
9/18
10:44 am
vcyt
Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago [Yahoo! Finance]
Low
Report
Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago [Yahoo! Finance]
9/15
08:46 am
vcyt
New Data Presented at ESMO 2024 Show that Veracyte's Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer [Yahoo! Finance]
Medium
Report
New Data Presented at ESMO 2024 Show that Veracyte's Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer [Yahoo! Finance]